149.45 USD
↘ 3.35 (2.19%)AT CLOSE (11:59 AM EDT)
Icon Plc
ICLRNASDAQ • USD
146.12
↘ 3.33 (2.23%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
146.12
↘ 3.33 (2.23%)
Market: CLOSED
Open?$151.78
High?$153.75
Low?$147.97
Prev. Close?$152.80
Volume?1.3M
Avg. Volume?1.4M
VWAP?$149.60
Rel. Volume?0.99x
Bid / Ask
Bid?$136.00 × 100
Ask?$155.00 × 2.0K
Spread?$19.00
Midpoint?$145.50
Valuation & Ratios
Market Cap?11.4B
Shares Out?76.4M
Float?80.3M
Float %?99.5%
P/E Ratio?33.88
P/B Ratio?5.92
EPS?$4.41
Dividend?0.00%
Ex-Dividend?N/A
Icon Plc (ICLR) is currently trading at $149.45. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". This is driven by a weak Piotroski F-Score of 0/9 and a bearish Death Cross on the long-term moving averages. On valuation, ICLR trades roughly in line with sector averages — neither particularly cheap nor expensive.
Technical & fundamental data as of Jun 5, 2026.
RelatedIQV
News
Profile
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?44
Momentum?50
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?2.25Grey
Confidence?57%Low
Short InterestModerate
Short % of Float?4.10%Low
Short Interest?3.3M
Days to Cover?3.5
Free Float80.3M
Avg Daily Volume937.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?2.01Strong
Quick Ratio?2.01Strong
Cash Ratio?0.87Adequate
Debt/Equity?0.18Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score56/100
P/E?33.9PRICEY▾
Peers50
S&P25
P/B?5.92FAIR▾
Peers50
S&P31
P/S?3.89FAIR▾
Peers50
S&P39
P/FCF?23.4FAIR▾
Peers50
S&P44
EV/EBITDA?23.1HIGH▾
Peers50
S&P18
EV/Sales?3.69FAIR▾
Peers50
S&P51
Returns & Efficiency
ROE?17.5%STRONG▾
Peers50
S&P61
ROA?9.7%STRONG▾
Peers100
S&P73
Cash Flow & Enterprise
FCF?$488.7M
Enterprise Value?$10.8B
Fundamentals ratios updated end of day